GlassScriptPhysician profile
Sean Michael Milligan
NPI 1861438061
$579,662.24
in general payments reported to CMS, 2019-2025
59 companies · $67K in 2025
The $67K reported for 2025 was more than what 97% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137K · 2020: $95K · 2021: $71K · 2022: $92K · 2023: $69K · 2024: $49K · 2025: $67K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $141K · Travel and Lodging: $20K · Consulting Fee: $14K · Food and Beverage: $8,994 · Education: $53.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $141,161.50 |
| Travel and Lodging | $20,357.70 |
| Consulting Fee | $13,990.50 |
| Food and Beverage | $8,993.68 |
| Education | $53.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $311,612.64 | 2019-2025 | Vumerity, Tysabri, Tysabri |
| Alexion Pharmaceuticals, INC. | $169,864.27 | 2019-2025 | Ultomiris, Soliris |
| Abbvie INC. | $38,159.80 | 2020-2025 | |
| Amgen INC. | $20,639.45 | 2020-2025 | Uplizna |
| Celgene Corporation | $15,189.17 | 2020-2025 | Zeposia |
| E.R. Squibb & Sons, L.L.C. | $8,908.56 | 2021-2023 | Zeposia |
| Kyowa Kirin, INC. | $5,228.91 | 2020-2024 | Nourianz |
| Medtronic, INC. | $1,068.66 | 2023-2024 | Percept PC Brainsense, Intellis Adaptivestim |
| Novartis Pharmaceuticals Corporation | $876.66 | 2019-2025 | |
| Boston Scientific Corporation | $754.65 | 2022 | |
| Emd Serono, INC. | $627.04 | 2019-2025 | Mavenclad |
| Pfizer INC. | $600.14 | 2023-2025 | |
| Neurocrine Biosciences, INC. | $473.88 | 2019-2025 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $473.49 | 2019-2025 | Austedo Xr, Austedo Xr |
| Supernus Pharmaceuticals, INC. | $433.30 | 2019-2023 |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $415.42 | 2023-2025 | Fintepla, Briviact, Nayzilam |
| Abbott Laboratories | $365.01 | 2021-2024 | Infinity |
| Genentech USA, INC. | $350.72 | 2019-2025 | Ocrevus Zunovo, Ocrevus, Enspryng |
| Allergan, INC. | $337.97 | 2019-2022 | |
| Genzyme Corporation | $261.13 | 2019-2023 | |
| Jazz Pharmaceuticals INC. | $247.38 | 2022-2025 | Epidiolex |
| Revance Therapeutics, INC. | $207.11 | 2024 | Daxxify |
| Biohaven Pharmaceutical Holding Company LTD. | $195.72 | 2022 | |
| Eisai INC. | $181.50 | 2024-2025 | |
| Sk Life Science, INC. | $169.41 | 2023-2025 | Xcopri |
| Axsome Therapeutics, INC. | $167.57 | 2023-2025 | Auvelity, Sunosi |
| Mdd US Operations, LLC | $144.57 | 2019 | |
| Medtronic USA, INC. | $136.20 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $124.65 | 2021 | |
| Amneal Pharmaceuticals LLC | $122.92 | 2021-2025 | Rytary, Crexont, Ongentys 50mg Capsules 30 |
| Ani Pharmaceuticals, INC. | $121.14 | 2022-2024 | Purified Cortrophin Gel |
| Argenx US, INC. | $113.52 | 2022-2024 | Vyvgart Hytrulo, Vyvgart |
| Akcea Therapeutics, INC. | $98.50 | 2019 | |
| Horizon Therapeutics Plc | $95.77 | 2021-2023 | Uplizna |
| Takeda Pharmaceuticals U.S.A., INC. | $91.26 | 2021-2025 | Entyvio |
| Harmony Biosciences LLC | $85.56 | 2022 | |
| Lilly USA, LLC | $83.99 | 2022-2024 | Kisunla |
| Lundbeck LLC | $76.25 | 2023-2025 | Vyepti, Rexulti |
| Merz Pharmaceuticals, LLC | $62.47 | 2024-2025 | Xeomin, Inbrija |
| Acadia Pharmaceuticals INC | $54.84 | 2019-2025 | Nuplazid |
| Greenwich Biosciences, INC. | $38.68 | 2021 | |
| Tg Therapeutics, INC. | $37.81 | 2023-2024 | |
| Acorda Therapeutics, INC | $35.54 | 2019-2022 | |
| Csl Behring | $33.52 | 2023-2024 | Hizentra |
| Otsuka America Pharmaceutical, INC. | $31.36 | 2024-2025 | Rexulti, Nuedexta |
| Ipsen Biopharmaceuticals, INC | $30.74 | 2022 | |
| Vanda Pharmaceuticals INC. | $30.04 | 2025 | Ponvory |
| Bayer Healthcare Pharmaceuticals INC. | $28.31 | 2022 | |
| Mylan Institutional INC. | $20.33 | 2023 | Hulio |
| Ge Healthcare | $18.88 | 2025 | |
| Cycle Pharmaceuticals INC | $18.47 | 2025 | Bafiertam, Tascenso Odt |
| Janssen Pharmaceuticals, INC | $17.90 | 2025 | |
| Promius Pharma LLC | $16.99 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $16.86 | 2022 | |
| Tersera Therapeutics LLC | $14.72 | 2025 | Quzyttir |
| Nestle Healthcare Nutrition INC. | $13.46 | 2022 | |
| Phathom Pharmaceuticals, INC. | $13.09 | 2025 | Voquezna |
| Avanir Pharmaceuticals, INC. | $12.18 | 2022 | |
| Impel Pharmaceuticals INC. | $12.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Milligan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.